We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

133 hedge funds and large institutions have $719M invested in Travere Therapeutics in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 60 increasing their positions, 39 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $76.4M | Put options by funds: $32.6M

54% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 39

47% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 17

6% more funds holding

Funds holding: 126 → 133 (+7)

25% less funds holding in top 10

Funds holding in top 10: 8 → 6 (-2)

34% less capital invested

Capital invested by funds: $1.09B → $719M (-$373M)

Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
3.71%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.17%
New
25
Increased
60
Reduced
39
Closed
17
Calls
$76.4M
Puts
$32.6M
Net Calls
+$43.8M
Net Calls Change
+$5.07M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$19.7M
2
SAM
Senzar Asset Management
New York
+$15.2M
3
Goldman Sachs
Goldman Sachs
New York
+$14.4M
4
Invesco
Invesco
Georgia
+$14.4M
5
BC
Broadfin Capital
New York
+$13.2M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$20.4M
2
Millennium Management
Millennium Management
New York
-$10.9M
3
LCM
Laurion Capital Management
New York
-$7.55M
4
WSA
Wall Street Associates
California
-$7.02M
5
PI
Putnam Investments
Massachusetts
-$5.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
RFC
76
Russell Frank Company
Washington
$535K -$1.02M -34,594 -57%
GAM
77
Gotham Asset Management
New York
$512K +$246K +8,307 +49%
Susquehanna International Group
78
Susquehanna International Group
Pennsylvania
$508K +$424K +14,316 +133%
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
$502K +$352K +11,873 +92%
MLICM
80
Metropolitan Life Insurance Company (MetLife)
New York
$499K – – –
JAM
81
JW Asset Management
Florida
$489K +$6.61K +223 +0.9%
DC
82
Deere & Company
Illinois
$472K +$44.5K +1,502 +7%
HCM
83
Highbridge Capital Management
New York
$467K +$682K +23,032 New
NFA
84
Nationwide Fund Advisors
Ohio
$459K – – –
TD Asset Management
85
TD Asset Management
Ontario, Canada
$448K +$17.8K +600 +3%
GC
86
Globeflex Capital
California
$434K +$634K +21,400 New
Citigroup
87
Citigroup
New York
$425K +$488K +16,474 +366%
HI
88
HBK Investments
Texas
$425K +$622K +21,000 New
AIG
89
American International Group
New York
$416K +$1.3K +44 +0.2%
Balyasny Asset Management
90
Balyasny Asset Management
Illinois
$384K +$561K +18,950 New
BFM
91
Boothbay Fund Management
New York
$368K +$539K +18,185 New
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$368K +$572K +19,305 New
TI
93
Trexquant Investment
Connecticut
$358K -$566K -19,100 -52%
DekaBank Deutsche Girozentrale
94
DekaBank Deutsche Girozentrale
Germany
$357K +$41.5K +1,400 +9%
Group One Trading
95
Group One Trading
Illinois
$348K +$468K +15,796 +1,165%
SEI Investments
96
SEI Investments
Pennsylvania
$338K +$495K +16,703 New
VOYA Investment Management
97
VOYA Investment Management
Georgia
$301K -$70.3K -2,373 -14%
VRS
98
Virginia Retirement Systems
Virginia
$283K +$415K +14,000 New
Dimensional Fund Advisors
99
Dimensional Fund Advisors
Texas
$251K – – –
Voloridge Investment Management
100
Voloridge Investment Management
Florida
$247K +$362K +12,209 New
2 3
4
5 6

TVTX Hedge Fund Activity: Q3 2015 in Review

133 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q3 2015, worth a combined $719M — down 34% from $1.09B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TVTX positions and 17 closed out — a net gain of 8 holders — while 60 added to existing stakes and 39 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $19.7M. The largest seller was Jennison Associates, cutting an estimated $20.4M.

  • 133 institutional investors held Travere Therapeutics (TVTX) as of Q3 2015, up from 126 in Q2 2015.
  • Funds reported $719M of Travere Therapeutics stock for Q3 2015, down 34% quarter-over-quarter.
  • 25 funds opened new Travere Therapeutics positions in Q3 2015 and 17 closed out, a net change of +8 holders.
  • The largest Travere Therapeutics buyer in Q3 2015 was EcoR1 Capital, an estimated $19.7M added.
  • The largest Travere Therapeutics seller in Q3 2015 was Jennison Associates, an estimated $20.4M sold.

Based on aggregated 13F filings for Q3 2015.